Trademark Overview
On Wednesday, June 11, 2025, a trademark application was filed for PROTEOLUTIONS with the United States Patent and Trademark Office. The USPTO has given the PROTEOLUTIONS trademark a serial number of 79433858. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, July 2, 2026. This trademark is owned by Proteolutions UG (haftungsbeschränkt). The PROTEOLUTIONS trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Biological preparations for use in industry and science; nucleic recombinant acids, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for protein expression, other than for medical use or veterinary purposes; Nucleic acid sequences, namely, codon-optimized DNA sequences for universal protein expression in a variety of production organisms, other than for medical use or veterinary purposes; Protein in raw material form for scientific and medical research and protein for industrial use, namely, recombinant proteins, protein sequences, for use in industry, science, in particular, in silico designed binding proteins; Nucleic acids, other than for medical or veterinary purposes, namely, nucleic acid sequencing programs.
Medical and veterinary preparations, namely, biological and biochemical reagents for medical or veterinary purposes, and diagnostic agents, preparations and substances for medical and veterinary purposes; nucleic recombinant acids and nucleic recombinant sequences, for medical use; biological and biochemical reagents for medical or veterinary purposes, namely, recombinant proteins and protein sequences, for medical use, especially, in silico designed protein agents; biological and biochemical reagents for medical or veterinary purposes, namely, codon-optimized DNA sequences for protein expression, for medical use.
Recorded content, namely, recorded computer programs for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents, and electronic data files and databases recorded on computer media in the field of codon optimized DNA sequences for protein expression; downloadable software, including downloadable application software, system and system support software and firmware, web applications and server software, artificial intelligence software and machine learning software for codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents; computer interfaces and recorded application programming interface (API) software for the automated codon optimization of DNA sequences for protein expression and in silico design of binding proteins and protein agents
Scientific and technological services, namely, scientific research, analysis and product development in the field of codon-optimized DNA sequences for protein expression, binding proteins and protein-based agents, providing codon-optimized DNA sequence technology research information for protein expression and product research and design relating thereto; DNA screening and optimization for scientific research purposes, all of the above for use in industry, especially, the creation of codon-optimized DNA sequences for protein expression and the creation of codon-optimized DNA sequences for universal protein expression in a variety of production organisms; computer aided design services, in relation to binding proteins, protein-based agents; consultancy and information in relation to the aforesaid services, included in this class.
